{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-106095","form_type":"8-K","ticker":"TXMD","cik":"0000025743","company_name":"TherapeuticsMD, Inc.","filed_at":"2024-12-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.658745+00:00","generated_at":"2026-05-29T07:30:18.305095+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"TherapeuticsMD annual meeting votes: all director nominees elected, say-on-pay approved, auditor ratified","bullets":["All four board nominees elected: Thompson 4.60M for, Collins 4.73M, Naughton 4.64M, Roberts 4.63M; broker non-votes 1.97M each.","Non-binding advisory vote on 2023 exec comp: 4.61M for, 218K against, 30K abstain; broker non-votes 1.97M.","Ratification of Berkowitz Pollack Brant as auditor for FY2024: 6.44M for, 383K against, 12K abstain; no broker non-votes.","Meeting held Dec 5, 2024; quorum of 6.83M shares (59.2% of 11.53M outstanding shares)."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-106095","json":"https://secwatch.observer/filing/0001213900-24-106095.json","markdown":"https://secwatch.observer/filing/0001213900-24-106095.md","text":"https://secwatch.observer/filing/0001213900-24-106095.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/25743/000121390024106095/0001213900-24-106095-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/25743/000121390024106095/ea0223856-8k_therap.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T07:30:18.305095+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}